Prevail Therapeutics Inc is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. Its pipeline products include PR001, PR006 and PR 004.